Cardiometabolic Risk Increases Morbidity, Not Mortality, in ALD Cardiometabolic risk factors do not increase 5-year mortality in ALD but are linked to higher risk for liver complications, cardiovascular events, and infections.

Cardiometabolic risk factors in alcohol-associated #liverdisease identify a higher-risk phenotype characterized by substantially increased morbidity, despite no significant difference in overall mortality.
www.gastroenterologyadvisor.com/news/cardiometabolic-ris...

Proud to sponsor A3UK with Global Liver Institute. Thank you to everyone involved, especially the patients.

Living with a condition is hard, choosing to advocate for others as well is inspiring.

Special thanks to our patient rep, Peter Ernest for his continued support.

#liverdisease #publichealth

Liver Disease Symptoms Are Easy To Miss—Watch for These Red Flags If someone asked about your heart health, you could probably list off your cholesterol numbers or even your latest A1C reading. But when it comes to your liver, you might not know where to start. Live...

#Discover #Liver #LiverDisease #Health #LiverHealth #Medical

www.yahoo.com/health/condi...

💊 Effectiveness of silymarin with lifestyle intervention in NAFLD and metabolic syndrome: a prospective single-arm study

Sukeepaisarnjaroen et al.

www.drugsincontext.com/effectivenes...

#hepatology #liverdisease #NAFLD #MASLD #sylimarin #MetabolicSyndrome @medsky.social @me.pharmsky.app

Decoding m6A mRNA methylation by reader proteins in liver diseases

This review summarizes #m6A reader proteins in #LiverDisease, highlighting their roles in #RNAmetabolism, disease progression, & therapeutic potential, while emphasizing the promise of #SmallMoleculeInhibitors targeting reader–mRNA interactions.
#OpenAccess: doi.org/10.1016/j.ge...

Posttranscriptional reprogramming controls MASLD progression through chronic ER stress adaptation In vivo study shows diet-induced ER stress reprograms mRNA translation, promoting MASH and liver cancer progression.

MASLD progression is driven by posttranscriptional reprogramming that enables adaptation to chronic ER stress—initially protective but ultimately disease-promoting, revealing new therapeutic targets. #MASLD #LiverDisease

www.science.org/doi/10.1126/...

🎥 The gut virome matters !🦠
Researchers at KU Leuven (@kuleuvenuniversity.bsky.social) found viral changes in the gut linked to #ACLF, #infections, and mortality - opening new paths for early detection and intervention.
💡 It’s not just bacteria
#Microbiome #Virome #LiverDisease

youtu.be/K9MIlhK4K5g

Missed the abstract deadline? There is still time to submit a last-chance abstract for #SLAM2026! See details at slam26.asip.org

#LiverResearch #LiverDisease #LiverCancer #Hepatology #ASIPmeeting

Occasional Heavy Drinking Significantly Increases Liver Fibrosis Risk in Adults with MASLD A recent study from Keck Medicine of USC highlights that episodic heavy drinking—even just once a month—substantially increases the risk of advanced liver scarring, particularly in individuals with metabolic dysfunction–associated steatotic liver disease (MASLD). MASLD, affecting approximately one in three U.S. adults, is linked to conditions such as obesity, diabetes, and high blood pressure. Using data from over 8,000 adults collected through the National Health and Nutrition Examination Survey between 2017 and 2023, researchers compared individuals who engaged in episodic heavy drinking (four or more drinks for women, five or more for men in a single day) with those who consumed the same total alcohol amount more gradually. Findings indicate that episodic heavy drinkers with MASLD were nearly three times more likely to develop advanced liver fibrosis than non-episodic drinkers. Younger adults and men were more likely to binge drink, and higher quantities in a single session correlated with greater liver damage. The study emphasizes that liver health risk is not just about total alcohol consumption but also the pattern of drinking. Dr. Brian P. Lee, lead researcher, stresses that even moderate drinkers should avoid episodic heavy drinking due to its potential to accelerate liver damage.

Occasional Heavy Drinking Significantly Increases Liver Fibrosis Risk in Adults with MASLD

🤖 IA: It's clickbait ⚠️
👥 Usuarios: It's clickbait ⚠️

#liverdisease #bingedrinking #masld

View full AI summary:

Study affirms MRE as quantitative imaging biomarker Liver stiffness measurements agree between conventional MR elastography sequence and updated sequence, according to researchers.

Researchers say findings support use of the QIBA-2023 updated protocol for longitudinal liver stiffness assessment without compromising diagnostic performance #radiology #liverdisease #MRI

📑 Isolated anti‑HBc is the most durable marker of prior HBV infection after HBsAg loss, but it’s not always benign. It may signal resolved infection, occult HBV, or reactivation risk during immunosuppression.
➡️ https://ow.ly/xc3Q50YAOLR
🏷️ #HBV #LiverDisease 🫧#PearlsfromthePros

New research finds even occasional heavy drinking — just once a month — may raise the risk of serious liver scarring, even in otherwise moderate drinkers.
youtu.be/94DhGD7llUk

#LiverHealth #FattyLiver #LiverDisease #LiverFibrosis #BingeDrinking #HeavyDrinking

Fragmentomics could improve both liver and breast disease dx Volume 13, Issue 13 | April 2, 2026

ALSO IN THIS ISSUE
Match the #antibiotic to the #UTI in less than a day
#PREVENT predicts risk of more than #heartdisease
#Infectiousdisease update

open.substack.com/pub/sensitiv...

#sensitiveandspecific #diagnostics #fragmentomics #liverdisease #breastdisease #earlydetection

Jianpi Huoxue Decoction Ameliorates Alcohol-associated Liver Disease by Improving Intestinal Barrier Function in Rats

This study demonstrates that Jianpi Huoxue Decoction protects against #ALD by reducing LPS, strengthening #Intestinal barriers, and modulating #GutLiverAxis health. #medsky

To read: doi.org/10.1007/s115...

#Hepatology #LiverDisease #IntestinalBarrier #HerbalMedicine #AcademicBluesky

PSC is no joke. It's hard to pronounce and even harder to explain.
Share this graphic to help raise awareness and understanding of this rare, complex disease.
ℹ️ pscsupport.org.uk/all-about-psc/

#LetsBeatPSC #PSCSupport #RareDisease #LiverDisease #ChronicIllness #primarysclerosingcholangitis

🚨 DEADLINE REMINDER: Today is the last day to submit an abstract, apply for an award, and register at a discount for #SLAM2026! slam26.asip.org

#LiverResearch #LiverDisease #LiverCancer #Hepatology

⏳ ONE DAY LEFT! Finalize your #SLAM2026 abstract submission and award application for the March 31 deadline! slam26.asip.org

#LiverResearch #LiverDisease #LiverCancer #Hepatology #ASIPmeeting

Top 10 Foods That Reverse Fatty Liver and Help Shrink Liver Fat

Explore further! ✨🌿 bit.ly/2PP4mND

This video explains the top 10 foods that reverse fatty liver and how they can support healthy organ function naturally.

#liverdisease

Association Between Saturated Fatty Acid Intake and MASLD: Mediating Roles of Insulin Resistance and Serum Albumin | British Journal of Nutrition | Cambridge Core Association Between Saturated Fatty Acid Intake and MASLD: Mediating Roles of Insulin Resistance and Serum Albumin

New: "Higher intakes of short- and long-chain SFAs, both individually and collectively, are associated with higher odds of MASLD." #saturatedfat #liverdisease #MASLD #hepatology
www.cambridge.org/core/journal...

Prevalence and dietary factors associated with nonalcoholic fatty liver disease in a sample of obese middle-aged Egyptian women - Scientific Reports This study investigated the prevalence of Nonalcoholic Fatty Liver Disease (NAFLD) among a sample of middle-aged obese Egyptian women and explored the associations between nutritional status, dietary ...

New in @nature.com: ""Furthermore, a significant positive correlation was detected between #NAFLD score and total dietary fat, #saturatedfat and #cholesterol which was more prominent as the degree of fatty liver worsens." #liverdisease #hepatology
www.nature.com/articles/s41...

Dean David Perlmutter, MD opened our Pediatric Research Retreat with a powerful keynote on Alpha-1 Antitrypsin Disease 🔬 Genetic modifiers + autophagy-targeting drugs = incredible promise for liver disease! #Alpha1 #Autophagy #PedsResearch #LiverDisease @washumedicine.bsky.social

These speakers at #SLAM2026 will discuss metabolism and microbiome! Learn more at slam26.asip.org

#LiverResearch #LiverCancer #LiverDisease #Hepatology #ASIPmeeting

🩺 Advancing metabolic-associated steatotic liver disease (MASLD) care: This study reviews emerging pharmacological therapies and future directions for MASLD management.
#MASLD #Hepatology #LiverDisease
www.xiahepublishing.com/2688-9254/JE...

Join us on March 31st at 6PM ET! For details and to register for free, please visit: liveralliance.org/events/liver... #LiverTransplant #LiverHealth #LiverDisease #OrganDonor #OrganDonation #LiverDiseaseAwareness

⏰ ONE WEEK LEFT! Prepare your #SLAM2026 abstract submission and award application for the March 31 deadline! slam26.asip.org

#LiverResearch #LiverDisease #LiverCancer #Hepatology #ASIPmeeting

What You Should Know About The Most Common Liver Disease in the US Metabolic dysfunction–associated steatotic liver disease (MASLD), formerly known as nonalcoholic fatty liver disease (NAFLD), affects up to one in three

⚕️Metabolic dysfunction–associated steatotic liver disease (MASLD) affects up to 1 in 3 adults in the United States and is one of the leading causes of liver failure. 👉 https://t2m.io/Y3JR6mw

#55pluslife #health #liverdisease #MASLD #fattyliver (#notfoiegras) #yourhealth

A big step towards precision medicine!
🎥 youtu.be/pgrQVn8mPbk
Researchers at OUH are validating #biomarkers to predict which #cirrhosis patients may benefit from #albumin therapy - helping deliver the right treatment to the right patient

💡 Double-blind clinical ABL-Trial ongoing
#LiverDisease #ACLF

These speakers at #SLAM2026 will discuss liver cancer, plus feature two abstract-driven talks! Learn more at slam26.asip.org

#LiverResearch #LiverDisease #Hepatology #ASIPmeeting

A Million Trails
#WritersCommunity #authorsky #5amwritersclub #amwriting #6amwritersclub #Booksky #Poetry #BookLovers #poem #nature #arts #bebrave #chronicillness #liverdisease

🧬 Metabolomics is unlocking new possibilities in personalised medicine!

In MICROB-PREDICT, researchers showed that urine & stool can reveal even more #biomarker insights than blood🩸, helping predict outcomes in severe #LiverDisease earlier.

Christophe Junot (CEA) on YouTube:
📽️ youtu.be/TYObOSu_r2w